Table 7.
Rewarding and reinforcing effects of 2C and NBOMe drugs.
| Drug | CPP |
SA dose (mg/kg) |
Model | Ref | ||
|---|---|---|---|---|---|---|
| C57BL/6 J mice dose (mg/kg, IP) |
↑ number of infusions | active lever presses | inactive lever presses | IV | ||
| 2C-C | 10 | 0.03 | - | 0.03 | Sprague Dawley rats | [12] |
| 2C-P | 10 | 0.01, 0.03 | 0.01, 0.03 | 0.01 | Sprague Dawley rats | [12] |
| 25B-NBOMe | 1 | 0.03, 0.1, 0.3 | 0.03, 0.1, 0.3 | - | Sprague Dawley rats | [9] |
| 25D-NBOMe | 1 | 0.03 | 0.03 | - | Sprague Dawley rats | [14] |
| 25E-NBOMe | 0.1 | 0.03 | - | 0.01 | Sprague Dawley rats | [15] |
| 25H-NBOMe | 0.05, 0.1, 0.5 | 0.01 | 0.01 | - | C57BL/6 J mice | [13] |
| 25I-NBOMe | 0.3 | - | - | - | Sprague Dawley rats | [10] |
| 25N-NBOMe | 3 | 0.01 | - | - | Sprague Dawley rats | [11] |
CPP (conditioned place preference); IP (Intraperitoneal); IV (Intravenously); SA (self-administration).